Quote mark

Now, with LDC on board, we’ll be able to bring our solutions to more markets across the globe, in particular the US. We’ll also be investing further in our R&D function to make sure our products and components remain truly market leading. This is the start of an exciting journey for the whole team, the business and our customers.”

Paul Morris, CEO
BioZone Scientific

He added: “LDC quickly understood the potential of our technology but also the challenges in scaling a business like ours. The fact they’ve supported so many other specialist manufacturers to achieve their goals gave us confidence that they were the right partner for growth.”

John Green, Investment Director at LDC, said: “BioZone is a genuinely world-class business that lacks the scale it deserves. Working closely with the management team and our non-executives, we’re looking forward to helping Paul accelerate take-up of its category-leading products in its chosen markets.”

LDC was advised by Provantage (corporate finance), KPMG (financial due diligence), Armstrong Transaction Services (commercial due diligence) and Browne Jacobson (legals).

The financial terms of the transaction are undisclosed.